Hearings find FDA, state regulators could have stopped outbreak

Congressional hearings and the papers they generated about meningitis deaths tied to the New England Compounding Center indicate that the FDA and state regulators had chances to prevent the outbreak. The records compiled by congressional committees reflect the need for a central data bank on licensed pharmacies, according to this article.

View Full Article in:

Tennessean (Nashville) (tiered subscription model), The

Published in Brief: